S100a9 - S100 calcium binding protein A9 Gene

Also Known as Mrp14

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 94195

Summary

Predicted to enable calcium ion binding activity and calcium-dependent protein binding activity. Involved in several processes, including autocrine signaling; response to ethanol; and response to lipopolysaccharide. Located in extracellular space. Biomarker of urinary bladder Cancer. Human ortholog(s) of this gene implicated in myocarditis. Orthologous to human S100A9 (S100 calcium binding protein A9). [provided by Alliance of Genome Resources, Apr 2022]

S100a9 Products (1)

mRNA Protein Name
NM_053587.2 NP_446039.2 protein S100-A9

Gene Ontology

  • Biological Process
  • Cellular Component
Biological Process GO Annotation Evidence References Source
involved in autocrine signaling IGI
IGI: Inferred from genetic interaction
27312849 RGD
involved in chronic inflammatory response IEP
IEP: Inferred from expression pattern
8343166 RGD
involved in positive regulation of neuron projection development IDA
IDA: Inferred from direct assay
23825416 RGD
involved in response to ethanol IEP
IEP: Inferred from expression pattern
17207109 RGD
involved in response to lipopolysaccharide IEP
IEP: Inferred from expression pattern
17207109 RGD
involved in response to zinc ion IEP
IEP: Inferred from expression pattern
19111725 RGD
Cellular Component GO Annotation Evidence References Source
located in extracellular space IDA
IDA: Inferred from direct assay
15221771 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

protein S100-A9

  • MRP-14

  • S100 calcium binding protein A9 (calgranulin B)

  • calgranulin-B

  • intracellular calcium-binding protein (MRP14)

  • migration inhibitory factor-related protein 14

  • myeloid-related protein 14

  • p14

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-10528 Tasquinimod Modulator 99.70% Phase 3
HY-100442 Paquinimod Inhibitor 99.90% Phase 2

Pre-clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-100442S1 Paquinimod-d5-1 Inhibitor 98.19% Unkown
HY-10528S Tasquinimod-d3 Modulator 99.34% Unkown
HY-RS12386 S100A9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS16579 S100a9 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-178053 AHR agonist 10 / Unkown
HY-181576 ROCK2-IN-14 Inhibitor / Unkown
HY-100442S Paquinimod-d5 Inhibitor / Unkown
HY-RS23013 S100a9 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991517 BI-836858 95.81% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens S100a9 NCBI NCBI:6280